| This sample attributes table contains sample IDs, sample type, analyte type, tumor status, histological type, tumor treatment, and name of the center which conducted sequencing. | Name of the center which conducted sequencing | phv00273669.v2.p1 |
| This sample attributes table contains sample IDs, sample type, analyte type, tumor status, histological type, tumor treatment, and name of the center which conducted sequencing. | Tumor status | phv00273666.v2.p1 |
| This subject phenotype table contains subject IDs, response upon anti-CTLA4 treatment or IFNgamma-stimulation, sex, and disease onset age. | Disease onset age | phv00273662.v1.p1 |
| This subject phenotype table contains subject IDs, response upon anti-CTLA4 treatment or IFNgamma-stimulation, sex, and disease onset age. | De-identified Subject ID | phv00273659.v1.p1 |
| This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use. | Source repository where samples originate | phv00273656.v2.p1 |
| The subject consent file includes subject IDs, consent information, subject aliases, and affection status of the subject for melanoma tumor. | Case control status of the subject for melanoma tumor | phv00273653.v1.p1 |
| This sample attributes table contains sample IDs, sample type, analyte type, tumor status, histological type, tumor treatment, and name of the center which conducted sequencing. | De-identified Sample ID | phv00273663.v2.p1 |
| This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use. | Sample ID used in the source repository | phv00273657.v2.p1 |
| This subject phenotype table contains subject IDs, response upon anti-CTLA4 treatment or IFNgamma-stimulation, sex, and disease onset age. | Response upon anti-CTLA4 treatment or IFNg-stimulation | phv00273660.v1.p1 |
| The subject consent file includes subject IDs, consent information, subject aliases, and affection status of the subject for melanoma tumor. | Consent group as determined by DAC | phv00273650.v1.p1 |
| This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use. | Subject ID | phv00273654.v2.p1 |
| The subject consent file includes subject IDs, consent information, subject aliases, and affection status of the subject for melanoma tumor. | Source repository where subjects originate | phv00273651.v1.p1 |
| This sample attributes table contains sample IDs, sample type, analyte type, tumor status, histological type, tumor treatment, and name of the center which conducted sequencing. | What type of sample was collected | phv00273664.v2.p1 |
| This sample attributes table contains sample IDs, sample type, analyte type, tumor status, histological type, tumor treatment, and name of the center which conducted sequencing. | Cell or tissue type or subtype of sample | phv00273667.v2.p1 |
| This subject phenotype table contains subject IDs, response upon anti-CTLA4 treatment or IFNgamma-stimulation, sex, and disease onset age. | Gender of participant | phv00273661.v1.p1 |
| The subject consent file includes subject IDs, consent information, subject aliases, and affection status of the subject for melanoma tumor. | Subject ID | phv00273649.v1.p1 |
| The subject consent file includes subject IDs, consent information, subject aliases, and affection status of the subject for melanoma tumor. | Subject ID used in the source repository | phv00273652.v1.p1 |
| This sample attributes table contains sample IDs, sample type, analyte type, tumor status, histological type, tumor treatment, and name of the center which conducted sequencing. | Type of tumor treatment for sample | phv00273668.v2.p1 |
| This sample attributes table contains sample IDs, sample type, analyte type, tumor status, histological type, tumor treatment, and name of the center which conducted sequencing. | Analyte Type | phv00273665.v2.p1 |
| This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use. | Sample Use | phv00273658.v2.p1 |